GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes
Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C
Known for its psychology-based approach to weight loss, Noom now offers compounded semaglutide and brand-name Zepbound alongside structured coaching, nutrition guidance, and accountability tools
Typical requirements include: BMI 40 documented atherosclerotic cardiovascular disease use of a specific Wegovy prior authorization form Key Takeaways Determine whether the patient ever had diabetes Use the correct diagnosis code on the prior authorization Verify whether the insurance plan covers weight-management medications Document baseline weight when starting therapy Consider secondary indications for Medicare coverage Final Thoughts Prior authorizations for GLP-1 medications can be complex and time-consuming
It is designed for self-use at home, resembling a pen, making it portable and easy to carry for on-the-go use
How long can I stay on a GLP-1 medication
